Qualigen Therapeutics, Inc.
About Us
Our Company
Leadership
Why We Do It
Board of Directors
Qualigen’s Strategic Partners
Careers at Qualigen
Contact Us
Therapeutics
Pipeline
AS1411
ALAN
ALAN-RE
ALAN-CE
STARS
RAS-F
Resource Literature
AS1411 Resource Literature
RAS Resource Literature
Diagnostics
FastPack® IP
Patients
Clinical Trials
Investors
Overview
News & Events
Company Info
Financial Info
Stock Data
SEC Filings
Governance
Customer Support
Ordering
Technical Support
SDS
OnQ Training
Financial Results
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
2021
Q2 2021
Quarter Ended Sep 30, 2020
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Q1 2021
Quarter Ended Jun 30, 2020
Earnings Release
PDF
HTML
10-Q
Filing
PDF
HTML
XBRL
ZIP
XLS
HTML
Email Alerts
Tear Sheet
Contacts
RSS News Feed